647 related articles for article (PubMed ID: 11932389)
1. Identification of neutralizing and nonneutralizing epitopes in the porcine reproductive and respiratory syndrome virus GP5 ectodomain.
Ostrowski M; Galeota JA; Jar AM; Platt KB; Osorio FA; Lopez OJ
J Virol; 2002 May; 76(9):4241-50. PubMed ID: 11932389
[TBL] [Abstract][Full Text] [Related]
2. The primary neutralization epitope of porcine respiratory and reproductive syndrome virus strain VR-2332 is located in the middle of the GP5 ectodomain.
Plagemann PG; Rowland RR; Faaberg KS
Arch Virol; 2002 Dec; 147(12):2327-47. PubMed ID: 12491101
[TBL] [Abstract][Full Text] [Related]
3. Neutralizing antibody responses of pigs infected with natural GP5 N-glycan mutants of porcine reproductive and respiratory syndrome virus.
Faaberg KS; Hocker JD; Erdman MM; Harris DL; Nelson EA; Torremorell M; Plagemann PG
Viral Immunol; 2006; 19(2):294-304. PubMed ID: 16817772
[TBL] [Abstract][Full Text] [Related]
4. The primary GP5 neutralization epitope of North American isolates of porcine reproductive and respiratory syndrome virus.
Plagemann PG
Vet Immunol Immunopathol; 2004 Dec; 102(3):263-75. PubMed ID: 15507310
[TBL] [Abstract][Full Text] [Related]
5. Neutralizing antibody formation in swine infected with seven strains of porcine reproductive and respiratory syndrome virus as measured by indirect ELISA with peptides containing the GP5 neutralization epitope.
Plagemann PG
Viral Immunol; 2006; 19(2):285-93. PubMed ID: 16817771
[TBL] [Abstract][Full Text] [Related]
6. The amino acid residues at 102 and 104 in GP5 of porcine reproductive and respiratory syndrome virus regulate viral neutralization susceptibility to the porcine serum neutralizing antibody.
Fan B; Liu X; Bai J; Zhang T; Zhang Q; Jiang P
Virus Res; 2015 Jun; 204():21-30. PubMed ID: 25907991
[TBL] [Abstract][Full Text] [Related]
7. GP5 ectodomain epitope of porcine reproductive and respiratory syndrome virus, strain Lelystad virus.
Plagemann PG
Virus Res; 2004 Jun; 102(2):225-30. PubMed ID: 15084406
[TBL] [Abstract][Full Text] [Related]
8. Replacing the decoy epitope of PCV2 capsid protein with epitopes of GP3 and/or GP5 of PRRSV enhances the immunogenicity of bivalent vaccines in mice.
Jung BK; Kim HR; Jang H; Chang KS
J Virol Methods; 2020 Oct; 284():113928. PubMed ID: 32650038
[TBL] [Abstract][Full Text] [Related]
9. Enhanced immunogenicity of the modified GP5 of porcine reproductive and respiratory syndrome virus.
Fang L; Jiang Y; Xiao S; Niu C; Zhang H; Chen H
Virus Genes; 2006 Feb; 32(1):5-11. PubMed ID: 16525729
[TBL] [Abstract][Full Text] [Related]
10. Dissociation of porcine reproductive and respiratory syndrome virus neutralization from antibodies specific to major envelope protein surface epitopes.
Li J; Murtaugh MP
Virology; 2012 Nov; 433(2):367-76. PubMed ID: 22981434
[TBL] [Abstract][Full Text] [Related]
11. Monoclonal antibodies and conserved antigenic epitopes in the C terminus of GP5 protein of the North American type porcine reproductive and respiratory syndrome virus.
Zhou YJ; Yu H; Tian ZJ; Liu JX; An TQ; Peng JM; Li GX; Jiang YF; Cai XH; Xue Q; Wang M; Wang YF; Tong GZ
Vet Microbiol; 2009 Jul; 138(1-2):1-10. PubMed ID: 19427138
[TBL] [Abstract][Full Text] [Related]
12. Monoclonal antibodies to the GP5 of porcine reproductive and respiratory syndrome virus are more effective in virus neutralization than monoclonal antibodies to the GP4.
Weiland E; Wieczorek-Krohmer M; Kohl D; Conzelmann KK; Weiland F
Vet Microbiol; 1999 Apr; 66(3):171-86. PubMed ID: 10227120
[TBL] [Abstract][Full Text] [Related]
13. The major envelope protein, GP5, of a European porcine reproductive and respiratory syndrome virus contains a neutralization epitope in its N-terminal ectodomain.
Wissink EHJ; van Wijk HAR; Kroese MV; Weiland E; Meulenberg JJM; Rottier PJM; van Rijn PA
J Gen Virol; 2003 Jun; 84(Pt 6):1535-1543. PubMed ID: 12771423
[TBL] [Abstract][Full Text] [Related]
14. Establishment of Systems to Enable Isolation of Porcine Monoclonal Antibodies Broadly Neutralizing the Porcine Reproductive and Respiratory Syndrome Virus.
Goldeck D; Perry DM; Hayes JWP; Johnson LPM; Young JE; Roychoudhury P; McLuskey EL; Moffat K; Bakker AQ; Kwakkenbos MJ; Frossard JP; Rowland RRR; Murtaugh MP; Graham SP
Front Immunol; 2019; 10():572. PubMed ID: 30972067
[TBL] [Abstract][Full Text] [Related]
15. Isolation of Porcine Reproductive and Respiratory Syndrome Virus GP5-Specific, Neutralizing Monoclonal Antibodies From Hyperimmune Sows.
Young JE; Dvorak CMT; Graham SP; Murtaugh MP
Front Immunol; 2021; 12():638493. PubMed ID: 33692807
[TBL] [Abstract][Full Text] [Related]
16. Influence of N-linked glycosylation of porcine reproductive and respiratory syndrome virus GP5 on virus infectivity, antigenicity, and ability to induce neutralizing antibodies.
Ansari IH; Kwon B; Osorio FA; Pattnaik AK
J Virol; 2006 Apr; 80(8):3994-4004. PubMed ID: 16571816
[TBL] [Abstract][Full Text] [Related]
17. GP5 of porcine reproductive and respiratory syndrome virus (PRRSV) as a target for homologous and broadly neutralizing antibodies.
Popescu LN; Trible BR; Chen N; Rowland RRR
Vet Microbiol; 2017 Sep; 209():90-96. PubMed ID: 28528961
[TBL] [Abstract][Full Text] [Related]
18. Linear epitope recognition antibodies strongly respond to the C-terminal domain of HP-PRRSV GP5.
Wang X; Qui L; Dang Y; Xiao S; Zhang S; Yang Z
Vet Microbiol; 2014 Dec; 174(3-4):565-569. PubMed ID: 25448446
[TBL] [Abstract][Full Text] [Related]
19. DNA vaccines co-expressing GP5 and M proteins of porcine reproductive and respiratory syndrome virus (PRRSV) display enhanced immunogenicity.
Jiang Y; Xiao S; Fang L; Yu X; Song Y; Niu C; Chen H
Vaccine; 2006 Apr; 24(15):2869-79. PubMed ID: 16446016
[TBL] [Abstract][Full Text] [Related]
20. Nsp2 and GP5-M of Porcine Reproductive and Respiratory Syndrome Virus Contribute to Targets for Neutralizing Antibodies.
Su J; Zhou L; He B; Zhang X; Ge X; Han J; Guo X; Yang H
Virol Sin; 2019 Dec; 34(6):631-640. PubMed ID: 31347089
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
